Menu

Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy.

Amgen Options Trading: A Deep Dive into Market Sentiment ↗

February 23, 2024

Via Benzinga

Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On. ↗

February 23, 2024

With new innovation and high demand, biotech stocks could offer some of the most explosive opportunities of the year.

3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024 ↗

February 22, 2024

Has Amgen been a market-beating stock?

If You Invested $20,000 in Amgen in 2014, This Is How Much You Would Have Today ↗

February 17, 2024

Exploring AMGEN INC (NASDAQ:AMGN)'s dividend characteristics.

This Is What Whales Are Betting On Amgen ↗

February 15, 2024

Via Benzinga

Behind the Scenes of Amgen's Latest Options Trends ↗

February 12, 2024

Via Benzinga

Why the dividend investor may take a look at NASDAQ:AMGN. ↗

February 12, 2024

Via Chartmill

Amgen Dips Despite Beating Fourth-Quarter Sales Expectations ↗

February 06, 2024

Amgen beat sales and earnings estimates late Tuesday, helped by nine products that hit record sales.

Although the healthcare innovation space has struggled recently, these contrarian biotech stocks now offer compelling discounts.

7 Contrarian Biotech Stocks to Consider Amid Sector Weakness ↗

February 15, 2024

Obesity drug sales boomed in 2023 and will continue in 2024. That could make these weight loss stocks even more attractive.

7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution ↗

February 14, 2024

2 Dow Jones Dividend Stocks With Above-Average Yields to Buy Now and Hold for at Least a Decade ↗

February 14, 2024

Investors interested in a steadily rising stream of passive income will find what they're looking for with these dividend payers.

It faces both clinical and competitive barriers, but they might not matter.

Topics Stocks

Amgen Takes Aim at Novo Nordisk and Eli Lilly, but Is the Stock a Buy? ↗

February 14, 2024

As opposed to drivers who overestimate themselves, we seek to be above-average stock pickers by doing the things that most professional investors struggle with, like being courageous and patient.

Drivers And Stock Pickers ↗

February 13, 2024

Via Talk Markets

Earnings Scheduled For February 6, 2024 ↗

February 06, 2024

Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion.

Via Benzinga

Preview: Amgen's Earnings ↗

February 05, 2024

Via Benzinga

Stock Market Hits Highs As AI Plays Arm, Palantir Skyrocket: Weekly Review ↗

February 08, 2024

The S&P 500 hit 5,000. Arm, Palantir and Cloudflare rose sharply.

These three Dow laggards have suffered double-digit percentage declines this winter, contributing to the Dow’s underperformance versus other major averages.

Topics Artificial Intelligence Stocks

Are these frigid Dow stocks in for a longer winter?

February 08, 2024

Via MarketBeat

Topics Economy Stocks

2 Unstoppable Stocks to Buy and Hold for 2024 and Beyond ↗

February 08, 2024

These great businesses are persisting and thriving through challenging economic times.

Investors' Focus Around Amgen's Obesity Drug Data Shadows Better Than Expected Q4 Earnings ↗

February 07, 2024

Amgen's Q4 2023: 15% net profit growth, $8.2 billion total revenues beat expectations. Prolia leads with 12% sales jump. Analysts' reactions and price targets.

Via Benzinga

S&P 500 Flirts With 5,000 As Magnificent 7 Tops $13 Trillion, NYCB Sinks: What's Driving Markets Wednesday? ↗

February 07, 2024

Wednesday is a bullish day on Wall Street, with major large-cap indices extending record highs, aided by robust corporate earnings. Despite the overall market optimism, concerns linger within segments...

Via Benzinga

Topics Stocks

META The Next Great Dividend Growth Stock – Growth Stock – Either Or Both? ↗

February 07, 2024

A technical analysis of Meta Platforms Inc. (aka Facebook) and its recent initiation of a dividend.

Via Talk Markets

34% of the Dow Jones Industrial Average's Weighting Is Determined by Just 5 Stocks ↗

February 07, 2024

Five well-known Dow Jones components account for more than a third -- over 13,100 points -- of its value.

Some of the best stocks to buy in February according to MarketMaster AI suggest that a major economic recovery is underway.

Topics Stocks

The Top 25 Stocks to Buy Immediately According to AI: February 2024 Edition ↗

February 06, 2024

Tech Slides, Chinese Stocks Rebound, New York Community Bancorp Tumbles: What's Driving Markets Tuesday? ↗

Topics Artificial Intelligence

February 06, 2024

At noon trading in New York, major equity indices on Wall Street remain directionless as traders evaluate the future course of monetary policy ahead of several speeches by Federal Reserve officials in...

Via Benzinga

Topics Economy

US Stocks Brace For Another Day In The Red As Rally Loses Steam: Analyst Sees Market Pullback On This Indicator ↗

February 06, 2024

The stock rally that propelled the S&P 500 and the Dow to record highs last week seems to have stalled, with Fed officials remaining non-committal about rate-cut plans.

Via Benzinga

Topics Economy Stocks

3 Fantastic Dow Stocks to Buy in February 2024 ↗

February 05, 2024

The venerable index is more representative of today's economy and these three Dow stocks to buy are brightly shining component stars.

The relaunch of Wegovy last year caused a mad dash by weight loss stocks to compete for market leadership in anti-obesity drugs.

Topics Economy Stocks

NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment? ↗

February 05, 2024

Amgen Is Trying To Take On Lilly, Novo In Obesity Treatment — Here's Why Lilly Stock Just Hit A Record ↗

February 05, 2024

Amgen is looking to rival Eli Lilly and Novo Nordisk in weight-loss drugs.